On the outside, Jackson Ramirez lives largely as any 7-year-old might. He jumps in streams, prefers his pretzels with queso, and loves family board games and dance parties at home.
On the inside, Jackson, a Zelienople first-grader known as Jax, is one in 1.6 million. That’s the rarity of a genetic disease known as IPEX syndrome, which doctors have discovered is wreaking havoc with his immune system. It’s often fatal.
A marrow transplant offers Jax’s only shot at a cure, the lone path to a rebuilt immune system promising a full and healthy life. But because he is of mixed ethnicity, lining up a well-matched donor is a fight with the clock — an excruciating challenge faced disproportionately by patients of minority lineages, including Black, Hispanic and Asian ancestry.
In the U.S. alone, thousands of people with blood cancers or disorders need such infusions, commonly known as bone-marrow or blood stem cell transplants.
“They say it’s going to be like finding a needle in a haystack or winning the lottery. And it’s only because there’s not enough diversity on the registry” of donors, said Jax’s mother, Melissa Ramirez, 43, who is leading a push to sign up more prospective donors for that international list.
Her ethnic background is a “melting pot” of German, Irish and Slovak; her husband, Pete Ramirez, 44, is of Mexican and German heritage, she said. Patients with Hispanic ancestry have a 48% chance of finding a well-suited prospect among more than 39 million potential donors registered around the world, according to the registry organization Be the Match, based in Minneapolis.
Black patients fare worse, with a 29% chance; Asian patients, 47%; Native American patients, 60%; and white patients, 79%, the group noted. Each year, about 12,000 leukemia, lymphoma, immune-deficient and other patients in the U.S. need marrow or blood stem cell transplants from unrelated donors, according to Be the Match, part of the nonprofit National Marrow Donor Program.
“Right now we’re facilitating close to 6,500 a year. There are thousands more who are waiting for that donor,” said Erica Sevilla, a spokeswoman for Be the Match. “It’s really, really important that individuals look to contribute what they can.”
Why genetics matter
Racial gaps persist in part from the science of marrow transplantation, which is more complex than matching blood types, doctors explained. Marrow transplants hinge on inherited proteins called HLAs — for human leukocyte antigens — which are shaped by genetics. HLAs alert the body’s immune defenses to cells that don’t belong.
To identify a good donor-patient match, doctors look for close similarities in HLA markers. Full biological siblings may be an excellent match and are often preferred, said Dr. William Hogan, director of blood and marrow transplantation at the Mayo Clinic in Rochester, Minn.
When that doesn’t work out, an unrelated living donor may be the next option.
“Because the HLA types we inherit are somewhat dependent on our ethnicity, it is a bit more likely that we would find a well-matched donor in a similar ethnic group, particularly when the recipient has a rare HLA type,” Dr. Hogan said.
Still, among Black Americans especially, finding an HLA match can be a challenge for a couple of reasons, Dr. Hogan said.
First, HLA diversity is much greater among African Americans, making it statistically more challenging to locate matches, he said. Further, because of a complex history, Black Americans’ lack of overall confidence in the health system may contribute to their underrepresentation in the donor registry, he added.
According to Be the Match, Black Americans are more likely than whites not to trust doctors, research shows, because of historic mistreatment of Black patients in health care and medical experimentation. Black people make up about 8% of the global registry of potential marrow and blood stem-cell donors; Hispanic people, about 13%; and people of more than one race, about 9%

“There’s been a lot of effort over the years to try to increase the diversity of the registry,” including through outreach in underrepresented communities, Dr. Hogan said.
Another hurdle is general misunderstanding, or lack of awareness, about donating, advocates said. Be the Match registers would-be donors between the ages of 18 and 40. Joining the registry requires a cheek swab that can be requested through bethematch.org and returned by mail.
Those added to the list remain there until they’re 61 years old, provided they don’t ask to be removed. Just more than 9 million people in the U.S. appear on the registry. In 2020, Be the Match added over 325,000 potential donors in the country, 33% of them ethnically diverse.
If a registry member’s HLA type matches a patient’s, that person will be asked to donate. About half the time, the would-be donor agrees, Ms. Sevilla said.
“People are very busy. We get that,” she said. “We understand this is a little bit of a disruption from your life. But it is a chance to save a life. You could be the only hope for that patient.”
How donation works
Everyone age 18-40 who is in good health and willing to donate to any patient is encouraged to join the Be The Match Registry.
Some people may be ineligible because of health conditions.
The donation process may take one of two forms, each extracting blood stem cells that doctors then introduce to replace unhealthy blood-forming cells in the recipient. Most donations now involve a nonsurgical, outpatient procedure called apheresis. For several days before giving, the donor receives injections of a drug such as filgrastim, which Dr. Hogan said releases stem cells from bone marrow into the blood.
During apheresis, blood is drawn from one arm through a needle and sent into a machine that removes stem cells. The blood returns to the other arm through another needle. Usually, the process takes one session, or two sessions on consecutive days. Filgrastim may cause short-term headaches or bone or muscle aches.
In some cases, clinicians still collect cells by using hollow needles to extract liquid bone marrow from the pelvic bone after administering anesthesia. The surgical procedure may involve an overnight stay; side effects can include temporary back or hip pain and fatigue.
Following either approach, the donor’s body regenerates to replace the donated cells.
“It took a few hours under anesthesia. I was discharged that day,” said Nikki Nastasi, 32, of Forest Hills, who underwent marrow extraction from her pelvis in 2016. “Pain-wise, there was just some sitting discomfort” for a day or two afterward.
She hasn’t met her recipient — a young boy with leukemia — but “would totally do it over and over again if I could,” Ms. Nastasi said. A former stem-cell specialist at UPMC Children’s Hospital of Pittsburgh, she works for a health technology firm that supports bone-marrow transplantation and cell therapy programs.
“Throughout the whole process, I tried to keep a positive attitude. The minor discomfort that I experienced is nothing compared to what the recipient and their family is going through. If I could relieve even 1% of their pain, that was worth it to me,” Ms. Nastasi said. “It’s simply the human act of kindness — I can’t emphasize it enough.”

For Jax, who has endured diabetes and a host of other severe ailments, doctors are hoping someone’s kind act turns up a suitable match by this spring. One of his doctors, Dr. Hey Chong, said his condition neutralizes a key regulatory function, leading the body to see his own organs as foreign.
“We felt there had to be something that could tie this all together,” said Dr. Chong, an immunologist and division chief at UPMC Children’s who diagnosed Jax with IPEX syndrome in October.
In effect, a marrow transplant would give him his donor’s immune system, said another doctor on Jax’s team, Dr. Jessie Barnum, an attending physician of blood and marrow transplantation and cellular therapies at UPMC Children’s.
“With a lot of diseases, these patients truly have no other option. They will die without a transplant,” said Dr. Barnum. “If things go relatively well — once they’re a year out from the transplant, a lot of times you can barely tell everything they went through. It truly changes the patient’s life.”
A donor who is only a partial match could be a possibility but would elevate the risk of post-transplant complications, Dr. Barnum said. Ongoing drug research offers hope for better outcomes for patients whose donors are imperfect matches, according to Be the Match.
The donor search
Ms. Ramirez is pouring herself into sign-ups for the donor registry. By the end of March, she said, her drive will have led to 80 live-donor solicitation events in the Pittsburgh area.
More are taking shape in Texas, Florida, Puerto Rico, Mexico and elsewhere, said Ms. Ramirez, who holds a doctoral degree in school psychology and is a psychologist in the Pine-Richland district. In early March, she estimated the push had led to at least 2,700 sign-ups of prospective donors.
An earlier scan of the registry didn’t identify any matches for Jax, but she hopes one will materialize among the newcomers. People can register on Jax’s behalf via https://my.bethematch.org/SaveJax or by texting “SaveJax” to 61474. Campaign updates appear at “bethematchforjax” on Facebook, TikTok and Instagram.
Given his Hispanic background, outreach is targeting places with Hispanic and Latino representation, Ms. Ramirez said. Another Pittsburgh-area family facing IPEX — a white family — saw 10 pages of potential donor matches while Jax struggles for a single prospect, she said.
No one should “wonder if their child is going to die because of their ethnicity,” she said.
Adam Smeltz is a freelance contributor and former city hall reporter for the Post-Gazette. He can be reached at asmeltz@gmail.com.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.